Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?

adaptive immune responses clearance genetics polymorphism hepatitis C virus immune escape viral variability

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
03 04 2019
Historique:
received: 23 02 2019
revised: 26 03 2019
accepted: 30 03 2019
entrez: 17 4 2019
pubmed: 17 4 2019
medline: 17 4 2019
Statut: epublish

Résumé

Hepatitis C virus (HCV) infection is the main cause of chronic hepatitis, affecting an estimated 150 million people worldwide. Initial exposure to HCV is most often followed by chronic hepatitis, with only a minority of individuals spontaneously clearing the virus. The induction of sustained and broadly directed HCV-specific CD4⁺ and CD8⁺ T cell responses, together with neutralizing antibodies (nAb), and specific genetic polymorphism have been associated with spontaneous resolution of the infection. However, due to its high variability, HCV is able to overwhelm the host immune response through the rapid acquisition of mutations in the epitopes targeted by T cells and neutralizing antibodies. In this context, immune-mediated pressure represents the main force in driving HCV evolution. This review summarizes the data on HCV diversity and the current state of knowledge about the contributions of antibodies, T cells, and host genetic polymorphism in driving HCV evolution in vivo.

Identifiants

pubmed: 30987134
pii: cells8040305
doi: 10.3390/cells8040305
pmc: PMC6523096
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Exp Med. 2005 Jun 6;201(11):1725-31
pubmed: 15939788
Curr Opin Virol. 2011 Dec;1(6):519-25
pubmed: 22328912
AIDS. 2014 Jan 2;28(1):133-6
pubmed: 24072198
Hepatology. 2010 Feb;51(2):378-87
pubmed: 19918975
J Virol. 2010 Feb;84(3):1656-63
pubmed: 19906915
Hepatology. 1997 May;25(5):1245-9
pubmed: 9141445
Int J Mol Med. 2012 Oct;30(4):945-52
pubmed: 22825757
Clin Infect Dis. 2005 Sep 1;41(5):667-75
pubmed: 16080089
J Viral Hepat. 2012 Mar;19(3):173-81
pubmed: 22329371
Aliment Pharmacol Ther. 2014 Mar;39(5):478-87
pubmed: 24387618
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3190-4
pubmed: 1373489
Gut. 2011 Nov;60(11):1563-71
pubmed: 21551190
J Virol. 2008 Apr;82(7):3438-51
pubmed: 18216107
Gastroenterology. 1999 Jan;116(1):135-43
pubmed: 9869611
Hepatology. 2016 Jan;63(1):63-73
pubmed: 26406534
J Exp Med. 2005 Jun 6;201(11):1741-52
pubmed: 15939790
J Virol. 2009 Jun;83(11):5760-4
pubmed: 19321623
PLoS Pathog. 2012;8(8):e1002881
pubmed: 22927817
Sci Rep. 2017 Feb 10;7:42408
pubmed: 28186161
J Hepatol. 2016 Oct;65(1 Suppl):S22-S32
pubmed: 27641986
Nat Med. 2013 Nov;19(11):1529-33
pubmed: 24162814
Nat Genet. 2017 May;49(5):666-673
pubmed: 28394351
PLoS One. 2012;7(1):e29370
pubmed: 22253715
J Exp Med. 2013 Jun 3;210(6):1109-16
pubmed: 23712427
J Hepatol. 2015 Nov;63(5):1103-10
pubmed: 26186989
Cell. 1978 Apr;13(4):735-44
pubmed: 657273
JCI Insight. 2017 May 4;2(9):
pubmed: 28469084
J Viral Hepat. 2011 May;18(5):305-15
pubmed: 21470343
Nat Genet. 2009 Oct;41(10):1100-4
pubmed: 19749758
PLoS Pathog. 2009 Feb;5(2):e1000313
pubmed: 19247441
J Infect Dis. 2011 Nov;204(9):1391-4
pubmed: 21933876
Nat Immunol. 2014 Aug;15(8):717-26
pubmed: 24952503
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):6025-30
pubmed: 17392433
J Virol. 2000 Jan;74(2):805-11
pubmed: 10623742
Nature. 2009 Sep 17;461(7262):399-401
pubmed: 19684573
Genet Mol Biol. 2016 Jul-Sep;39(3):374-9
pubmed: 27560987
J Hepatol. 2011 Dec;55(6):1201-6
pubmed: 21703201
Gastroenterology. 2011 Aug;141(2):686-95, 695.e1
pubmed: 21699897
J Gen Virol. 1992 Oct;73 ( Pt 10):2725-9
pubmed: 1383400
PLoS Pathog. 2017 Feb 24;13(2):e1006235
pubmed: 28235087
J Virol. 2009 Sep;83(18):9122-30
pubmed: 19587053
J Viral Hepat. 2019 Apr;26(4):476-484
pubmed: 30578702
Int J Cancer. 1996 Jul 17;67(2):199-203
pubmed: 8760588
Clin Microbiol Infect. 2011 Feb;17(2):107-15
pubmed: 21091831
Eur J Clin Microbiol Infect Dis. 2013 Jun;32(6):745-54
pubmed: 23314745
J Biol Chem. 2012 Oct 12;287(42):35631-45
pubmed: 22927442
J Virol. 2011 Jul;85(14):6963-76
pubmed: 21543474
Aliment Pharmacol Ther. 2014 Feb;39(3):322-30
pubmed: 24308755
Hepatology. 2014 Jan;59(1):318-27
pubmed: 24115039
Clin Res Hepatol Gastroenterol. 2015 Oct;39(5):576-83
pubmed: 25769643
Virology. 2006 Sep 1;352(2):357-67
pubmed: 16781757
J Virol. 2007 Aug;81(16):8374-83
pubmed: 17537845
Hepatology. 2007 Mar;45(3):588-601
pubmed: 17326153
Gene. 2013 Apr 15;518(2):479-82
pubmed: 23266640
J Virol. 2009 Mar;83(5):2163-77
pubmed: 19073716
Gastroenterology. 2007 Feb;132(2):667-78
pubmed: 17258731
Hepatology. 2002 May;35(5):1225-36
pubmed: 11981773
PLoS Pathog. 2008 Sep 05;4(9):e1000143
pubmed: 18773115
J Clin Invest. 2010 Dec;120(12):4546-57
pubmed: 21084749
PLoS One. 2012;7(5):e37054
pubmed: 22649509
Hepatol Res. 2013 Apr;43(4):327-38
pubmed: 22970660
J Med Virol. 2016 Feb;88(2):185-95
pubmed: 26211651
J Virol. 2005 May;79(10):6023-34
pubmed: 15857988
J Biol Chem. 1996 Jul 19;271(29):17174-82
pubmed: 8663414
Gastroenterology. 2012 Nov;143(5):1244-1252.e12
pubmed: 22841784
J Pediatr Gastroenterol Nutr. 2013 Aug;57(2):155-60
pubmed: 23880623
N Engl J Med. 2009 Apr 30;360(18):1827-38
pubmed: 19403902
PLoS Pathog. 2010 Dec 16;6(12):e1001233
pubmed: 21187906
J Virol. 2011 Nov;85(22):11833-45
pubmed: 21900166
J Infect. 2013 Feb;66(2):170-8
pubmed: 23103287
J Exp Med. 2004 Dec 20;200(12):1593-604
pubmed: 15611288
J Gen Virol. 2000 Jul;81(Pt 7):1631-48
pubmed: 10859368
J Virol. 2008 Dec;82(23):11803-12
pubmed: 18815309
J Virol. 2006 Nov;80(22):11094-104
pubmed: 17071929
Hepatology. 2014 Jan;59(1):109-20
pubmed: 23908124
N Engl J Med. 2011 Mar 31;364(13):1195-206
pubmed: 21449783
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15394-9
pubmed: 8986822
Hum Immunol. 2011 May;72(5):379-85
pubmed: 21377503
Gastroenterology. 2010 Nov;139(5):1586-92, 1592.e1
pubmed: 20637200
Virology. 2009 Apr 10;386(2):398-406
pubmed: 19232664
EMBO J. 1997 Oct 1;16(19):5894-903
pubmed: 9312047
Sci Am. 1981 Apr;244(4):88-92, 96, et passim
pubmed: 6164094
Sci Rep. 2018 May 8;8(1):7224
pubmed: 29740042
Nat Genet. 2013 Feb;45(2):164-71
pubmed: 23291588
J Virol. 2004 Oct;78(20):11288-95
pubmed: 15452248
Immunity. 2001 Dec;15(6):883-95
pubmed: 11754811
J Exp Med. 2012 Jan 16;209(1):61-75
pubmed: 22213804
J Infect Dis. 2014 Jun 1;209(11):1700-4
pubmed: 24367041
Microbiol Mol Biol Rev. 2012 Jun;76(2):159-216
pubmed: 22688811
Hepatology. 2012 Feb;55(2):384-94
pubmed: 22180014
World J Hepatol. 2015 Apr 28;7(6):831-45
pubmed: 25937861
J Virol. 2010 Jun;84(12):6218-28
pubmed: 20375170
Lancet. 1993 Oct 9;342(8876):933
pubmed: 7692197
Semin Liver Dis. 1995 Feb;15(1):41-63
pubmed: 7597443
Clin Infect Dis. 2008 Nov 15;47(10):1260-9
pubmed: 18834319
PLoS One. 2011;6(11):e27555
pubmed: 22110669
J Clin Invest. 2009 Feb;119(2):376-86
pubmed: 19139562
J Virol. 2002 Dec;76(24):12584-95
pubmed: 12438584
J Biol Chem. 2009 Jul 31;284(31):20869-75
pubmed: 19457860
Lancet. 2015 Mar 21;385(9973):1124-35
pubmed: 25687730
Nature. 2009 Oct 8;461(7265):798-801
pubmed: 19759533
J Gen Virol. 2015 Apr;96(Pt 4):727-738
pubmed: 25481754
J Virol. 2000 Mar;74(6):2541-9
pubmed: 10684268
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9822-7
pubmed: 17517620
J Mol Evol. 1997 Sep;45(3):238-46
pubmed: 9302317
Virus Res. 2009 Apr;141(1):55-62
pubmed: 19185598
Nat Commun. 2015 Mar 05;6:6422
pubmed: 25740255
J Virol. 1997 Aug;71(8):6011-9
pubmed: 9223492
J Immunol. 1999 Jul 15;163(2):650-8
pubmed: 10395654
J Exp Med. 2005 Jun 6;201(11):1753-9
pubmed: 15939791
J Exp Med. 2003 Mar 3;197(5):633-42
pubmed: 12615904
J Exp Med. 2001 Nov 19;194(10):1395-406
pubmed: 11714747
Lancet. 1995 Oct 14;346(8981):1006-7
pubmed: 7475549
Clin Infect Dis. 2013 Sep;57(6):803-11
pubmed: 23784926
Nature. 1977 May 19;267(5608):275-6
pubmed: 865622
Gastroenterology. 2010 Jul;139(1):120-9.e18
pubmed: 20399780
Front Immunol. 2014 Jun 16;5:274
pubmed: 24982656
Acta Med Okayama. 2001 Jun;55(3):133-59
pubmed: 11434427
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3081-6
pubmed: 11880647
Gastroenterology. 2010 Apr;138(4):1338-45, 1345.e1-7
pubmed: 20060832
Hepatol Int. 2015 Apr;9(2):251-7
pubmed: 25788203
Gut. 2012 Aug;61(8):1226-34
pubmed: 21873736
EMBO J. 2013 Nov 27;32(23):3055-65
pubmed: 24169568
Nat Rev Immunol. 2016 Aug;16(8):509-23
pubmed: 27374637
J Virol. 2008 Oct;82(20):10017-31
pubmed: 18667516
N Engl J Med. 1996 Jan 11;334(2):77-81
pubmed: 8531962
J Mol Evol. 1977 Aug 5;9(4):367-8
pubmed: 894738
J Virol. 2015 May;89(10):5478-90
pubmed: 25740982
Nat Immunol. 2003 Jan;4(1):63-8
pubmed: 12469119
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2755-9
pubmed: 7708719
Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7792-6
pubmed: 7519785
Gastroenterology. 2010 Jun;138(7):2307-14
pubmed: 20176026
Front Immunol. 2014 Nov 10;5:550
pubmed: 25426115
Annu Rev Microbiol. 1997;51:151-78
pubmed: 9343347
Gastroenterology. 1999 Oct;117(4):933-41
pubmed: 10500077
Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10149-54
pubmed: 15220475
Gastroenterology. 2011 Jun;140(7):2064-73
pubmed: 21376049
Nat Immunol. 2003 Jan;4(1):69-77
pubmed: 12483210
Nat Genet. 2009 Oct;41(10):1105-9
pubmed: 19749757
J Gen Virol. 2007 Dec;88(Pt 12):3323-33
pubmed: 18024902
Eur J Immunol. 2005 Sep;35(9):2627-37
pubmed: 16114108
Infect Genet Evol. 2008 Jan;8(1):74-82
pubmed: 18063425
Hepatology. 2014 Jun;59(6):2140-51
pubmed: 24425349
PLoS Pathog. 2010 Jun 10;6(6):e1000947
pubmed: 20548953
J Clin Invest. 1996 Aug 1;98(3):706-14
pubmed: 8698862
Science. 2000 Apr 14;288(5464):339-44
pubmed: 10764648
J Infect Dis. 2014 Feb 1;209(3):350-4
pubmed: 23956438
J Virol. 2011 Nov;85(22):11883-90
pubmed: 21880756
Gastroenterology. 2009 Jun;136(7):2377-86
pubmed: 19303013
Curr Opin Immunol. 2011 Oct;23(5):583-90
pubmed: 21840693
Biochem J. 2003 Mar 1;370(Pt 2):391-6
pubmed: 12521379
J Virol. 2007 Sep;81(17):9249-58
pubmed: 17567698
PLoS Pathog. 2011 Feb 10;7(2):e1001278
pubmed: 21347350
Front Immunol. 2018 Jun 28;9:1480
pubmed: 30002657

Auteurs

Daniele Lapa (D)

Laboratory of Virology, "L. Spallanzani" National Institute for Infectious Diseases, IRCCS, 00149 Rome, Italy. daniele.lapa@inmi.it.

Anna Rosa Garbuglia (AR)

Laboratory of Virology, "L. Spallanzani" National Institute for Infectious Diseases, IRCCS, 00149 Rome, Italy. argarbuglia@iol.it.

Maria Rosaria Capobianchi (MR)

Laboratory of Virology, "L. Spallanzani" National Institute for Infectious Diseases, IRCCS, 00149 Rome, Italy. maria.capobianchi@inmi.it.

Paola Del Porto (P)

Department of Biology and Biotechnology, "C. Darwin" Sapienza University, 00100 Rome, Italy. paola.delporto@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH